House Commerce Committee FDA reform bill unlikely before end of 1995 -- Rep. Barton.

This article was originally published in The Rose Sheet

31 Jul 1995
News

The Rose Sheet

Executive Summary

HOUSE COMMERCE COMMITTEE FDA REFORM BILL UNLIKELY BEFORE END OF 1995, according to Oversight Subcommittee Chairman Joe Barton (R-TX). The full Commerce Committee leadership is working first on other federal health issues and is unlikely to turn to FDA reform before 1996, Rep. Barton acknowledged.

Already Registered? Sign in to continue reading.

New to HBW Insight? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

RS001860

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

RS001860

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

House Commerce Committee FDA reform bill unlikely before end of 1995 -- Rep. Barton.

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert